5.48
price down icon8.05%   -0.48
after-market After Hours: 5.58 0.10 +1.82%
loading
Atai Life Sciences N V stock is traded at $5.48, with a volume of 6.44M. It is down -8.05% in the last 24 hours and up +17.85% over the past month. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$5.96
Open:
$6
24h Volume:
6.44M
Relative Volume:
1.07
Market Cap:
$1.17B
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-6.7654
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
+0.55%
1M Performance:
+17.85%
6M Performance:
+285.92%
1Y Performance:
+352.89%
1-Day Range:
Value
$5.475
$6.09
1-Week Range:
Value
$5.06
$6.30
52-Week Range:
Value
$1.04
$6.30

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Name
Atai Life Sciences N V
Name
Phone
49 89 2153 9035
Name
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ATAI's Discussions on Twitter

Compare ATAI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ATAI
Atai Life Sciences N V
5.48 1.40B 2.59M -137.89M -69.76M -0.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-29-25 Initiated Oppenheimer Outperform
Nov-18-24 Reiterated H.C. Wainwright Buy
Apr-03-24 Upgrade Maxim Group Hold → Buy
Nov-01-22 Initiated Loop Capital Buy
Nov-30-21 Initiated Maxim Group Buy
Nov-11-21 Initiated ROTH Capital Buy
Oct-18-21 Initiated H.C. Wainwright Buy
Sep-01-21 Initiated Jefferies Buy
Jul-13-21 Initiated Berenberg Buy
Jul-13-21 Initiated Canaccord Genuity Buy
Jul-13-21 Initiated Cantor Fitzgerald Buy
Jul-13-21 Initiated Citigroup Buy
Jul-13-21 Initiated Cowen Outperform
Jul-13-21 Initiated Credit Suisse Outperform
Jul-13-21 Initiated RBC Capital Mkts Sector Perform
Jul-08-21 Initiated Aegis Capital Buy
View All

Atai Life Sciences N V Stock (ATAI) Latest News

pulisher
05:55 AM

Atai Life Sciences N.V. (ATAI) Stock Rebounds as Company Launches New Share Offering - parameter.io

05:55 AM
pulisher
04:55 AM

ATAI Life Sciences and Beckley Psytech Announce FDA Breakthrough Therapy Designation for BPL-003 - TradingView

04:55 AM
pulisher
04:19 AM

Atai Life Sciences Gets FDA Breakthrough Designation for Depression Treatment - MarketScreener

04:19 AM
pulisher
04:13 AM

Can swing trading help recover from Atai Life Sciences N.V. lossesQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com

04:13 AM
pulisher
04:12 AM

atai Life Sciences Announces Proposed Public Offering of Common Shares - Yahoo

04:12 AM
pulisher
04:11 AM

Atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - MarketScreener

04:11 AM
pulisher
04:10 AM

atai Life Sciences Receives FDA Breakthrough for BPL-003 in TRD | ATAI Stock News - Stock Titan

04:10 AM
pulisher
Oct 15, 2025

Ranking Atai Life Sciences N.V. among high performing stocks via toolsWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Combining machine learning predictions for Atai Life Sciences N.V.2025 Macro Impact & Real-Time Volume Analysis - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How high can Atai Life Sciences N.V. stock goPortfolio Return Report & Community Trade Idea Sharing - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Can technical indicators confirm Atai Life Sciences N.V.’s reversal2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Atai Life Sciences N.V. stock retracement – recovery analysisInsider Buying & Daily Entry Point Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Psychedelic stocks up on remarks from GOP Senator (ATAI) - Seeking Alpha

Oct 14, 2025
pulisher
Oct 14, 2025

How institutional ownership impacts Atai Life Sciences N.V. stockQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside - Sahm

Oct 14, 2025
pulisher
Oct 14, 2025

Atai Life Sciences N.V. stock chart pattern explainedQuarterly Market Summary & Low Risk High Reward Trade Ideas - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Tick level data insight on Atai Life Sciences N.V. volatilityQuarterly Profit Report & Risk Managed Investment Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Quantitative breakdown of Atai Life Sciences N.V. recent moveJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Can Atai Life Sciences N.V. stock resist sector downturnsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

How Atai Life Sciences N.V. (9VC) stock responds to job market shiftsGold Moves & Short-Term Trading Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is now a turning point for Atai Life Sciences N.V.Profit Target & Verified Swing Trading Watchlists - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Needham Initiates ATAI Life Sciences N.V at Buy With $12 Price Target - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Needham Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Buy Recommendation - Nasdaq

Oct 13, 2025
pulisher
Oct 11, 2025

ATAI Life Sciences files update on Beckley Psytech acquisition plans By Investing.com - Investing.com Nigeria

Oct 11, 2025
pulisher
Oct 10, 2025

ATAI Life Sciences files update on Beckley Psytech acquisition plans - Investing.com

Oct 10, 2025
pulisher
Oct 10, 2025

ATAI Life Sciences to Acquire Beckley Psytech - TipRanks

Oct 10, 2025
pulisher
Oct 10, 2025

ATAI Life Sciences N.V. Announces Acquisition of Beckley Psytech - TradingView

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 04:54:45 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Gem With 107% Potential Upside - DirectorsTalk Interviews

Oct 10, 2025
pulisher
Oct 09, 2025

Can trapped investors hope for a rebound in Atai Life Sciences N.V.Portfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What to expect from Atai Life Sciences N.V. in the next 30 daysJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Evaluating Atai Life Sciences N.V. with trendline analysis2025 Market Overview & Fast Moving Stock Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What sentiment indicators say about Atai Life Sciences N.V. stockJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Atai Life Sciences N.V. stock outperform growth indexes2025 Market WrapUp & Safe Capital Growth Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to track smart money flows in Atai Life Sciences N.V.IPO Watch & Weekly Watchlist for Hot Stocks - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using RSI to spot recovery in Atai Life Sciences N.V.July 2025 Intraday Action & Expert Verified Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Short interest data insights for Atai Life Sciences N.V.2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Momentum divergence signals in Atai Life Sciences N.V. chartPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Oct 03, 2025

Atai Life Sciences N V Stock (ATAI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Cap:     |  Volume (24h):